Article Details

SpringWorks price target raised at Goldman Sachs after trial win for lead assets - Seeking Alpha

Retrieved on: 2022-05-24 16:11:13

Tags for this article:

Click the tags to see associated articles and topics

SpringWorks price target raised at Goldman Sachs after trial win for lead assets - Seeking Alpha. View article details on hiswai:

Excerpt

Goldman Sachs has increased the price target on SpringWorks Therapeutics (SWTX) on Tuesday after the clinical-stage biotech reported positive data ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up